Cellvoyant

Cellvoyant company information, Employees & Contact Information

Explore related pages

Related company profiles:

CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have the best investors behind us from day 1. We’re backed by venture capital firms who were the earliest investors in AI pioneer DeepMind, the two leading AI-first drug discovery companies, Exscientia and Recursion, and self-driving challenger Wayve. We’re also supported by the founder/CEO of Abcam, which pioneered the antibody business.

Company Details

Employees
19
Founded
-
Address
40 Berkeley Square, Bristol,england Bs8 1hp,united Kingdom
Industry
Biotechnology
Keywords
LettUs Grow.
HQ
Bristol, England
Looking for a particular Cellvoyant employee's phone or email?

Cellvoyant Questions

News

CellVoyant's AI-Powered Vision for the Future of Cell Therapy - News-Medical

CellVoyant's AI-Powered Vision for the Future of Cell Therapy News-Medical

CellVoyant Secures £7.6 Million in Seed Round - The SaaS News

CellVoyant Secures £7.6 Million in Seed Round The SaaS News

CellVoyant secures £7.6 million AI stem cell boost - PharmaTimes

CellVoyant secures £7.6 million AI stem cell boost PharmaTimes

Octopus-backed AI biotech CellVoyant raises £7.6m to make stem cell therapies cheaper - Sifted

Octopus-backed AI biotech CellVoyant raises £7.6m to make stem cell therapies cheaper Sifted

January: CellVoyant funding | News and features - University of Bristol

January: CellVoyant funding | News and features University of Bristol

Cell therapy’s next frontier: How AI is shaping the future - The AI Journal

Cell therapy’s next frontier: How AI is shaping the future The AI Journal

Bristol’s CellVoyant raises £7.6m to predict stem cell behaviour with AI - UKTN

Bristol’s CellVoyant raises £7.6m to predict stem cell behaviour with AI UKTN

£7.6m backing for MedTech pioneering stem cell therapy AI - BusinessCloud

£7.6m backing for MedTech pioneering stem cell therapy AI BusinessCloud

Bristol Uni AI biotech spin-out raises £7.6M - Insider Media Ltd

Bristol Uni AI biotech spin-out raises £7.6M Insider Media Ltd

Life Sciences Insights from Industry - News-Medical

Life Sciences Insights from Industry News-Medical

Top Cellvoyant Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant